Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1693-1704 of 1735 results
Page 142 of 145
Key Publications June 29, 2009

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Circulation 2009;119:805-11

Worm SW, De Wit S, Weber R et al.
Cardiovascular Disease Diabetes Prevention
Key Publications May 23, 2009

Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study.

Circulation 2009;119:1203-10

Parikh NI, Gona P, Larson MG et al.
Cardiovascular Disease Prevention
Key Publications March 9, 2009

Short sleep duration and incident coronary artery calcification.

JAMA 2008;300:2859-66

King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications January 18, 2009

Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.

Arch Intern Med 2008;168:2194-204

Giannuzzi P, Temporelli PL, Marchioli R et al.
Prevention
Key Publications January 15, 2009

Genotype score in addition to common risk factors for prediction of type 2 diabetes.

N Engl J Med 2008;359:2208-19

Meigs JB, Shrader P, Sullivan LM et al.
Diabetes Genetics Prevention
Key Publications November 15, 2008

Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu Diabetes Prevention Trial.

Diabetes Care 2008;31:1949-54

Kawahara T, Takahashi K, Inazu T et al.
Prevention
Key Publications October 25, 2008

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study.

Eur Heart J 2008;29:2244-51

Elkeles RS, Godsland IF, Feher MD et al.
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications October 22, 2008

Inhibition of lipoprotein-associated phospholipase activity by darapladib: shifting gears in cardiovascular drug development: are antiinflammatory drugs the next frontier?

Circulation 2008;118:1120-2

Boekholdt SM, de Winter RJ, Kastelein JJ
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications September 18, 2008

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia.

Nat Clin Pract Cardiovasc Med 2008;5:497-505

Samaha FF, McKenney J, Bloedon LT, Sasiela WJ, Rader DJ
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications September 17, 2008

Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II trial.

J Am Coll Cardiol 2008;52:626-32

Ballantyne CM, Raichlen JS, Cain VA
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications August 22, 2008

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

BMJ 2008;336:1475-82

Hippisley-Cox J, Coupland C, Vinogradova Y et al.
Cardiovascular Disease Diabetes Prevention
Key Publications August 20, 2008

Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.

Am J Med 2008;121:604-10

Coodley GO, Jorgensen M, Kirschenbaum J, Sparks C, Zeigler L, Albertson BD
Cardiovascular Disease Lipids/Lipoproteins Prevention
of 145